Deconstructing interstitial fibrosis and tubular atrophy: a step toward precision medicine in renal transplantation

被引:12
作者
Mengel, Michael [1 ]
机构
[1] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2S2, Canada
关键词
DONOR-SPECIFIC ANTIBODY; CREATININE; BIOPSIES;
D O I
10.1016/j.kint.2017.04.041
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The prerequisite for successful treatment is an accurate diagnosis, a concept coined precision medicine. Progression of interstitial fibrosis and tubular atrophy is widely considered the natural course for all transplanted kidneys. In this issue, Gosset et al. describe discrete disease entities in individual patients and their contribution to interstitial fibrosis and tubular atrophy and its progression. This represents a major step forward in stratifying patients for targeted treatment trials (i.e., a step toward precision medicine in renal transplantation).
引用
收藏
页码:553 / 555
页数:4
相关论文
共 9 条
[1]   Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study [J].
Beland, Marc-Antoine ;
Lapointe, Isabelle ;
Noel, Real ;
Cote, Isabelle ;
Wagner, Eric ;
Riopel, Julie ;
Latulippe, Eva ;
Desy, Olivier ;
Beland, Stephanie ;
Magee, Ciara N. ;
Houde, Isabelle ;
De Serres, Sacha A. .
TRANSPLANT INTERNATIONAL, 2017, 30 (05) :502-509
[2]   CORRELATIONS BETWEEN RENAL INTERSTITIUM AND LEVEL OF SERUM CREATININE - MORPHOMETRIC INVESTIGATIONS OF BIOPSIES IN PERI-MEMBRANOUS GLOMERULONEPHRITIS [J].
BOHLE, A ;
GRUND, KE ;
MACKENSEN, S ;
TOLON, M .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1977, 373 (01) :15-22
[3]  
Gosset C, KIDNEY INT
[4]   CREATININE EXCRETION AFTER RENAL-TRANSPLANTATION [J].
KASISKE, BL .
TRANSPLANTATION, 1989, 48 (03) :424-428
[5]   Precision Diagnostics in Transplantation: From Bench to Bedside [J].
Mengel, M. ;
Campbell, P. ;
Gebel, H. ;
Randhawa, P. ;
Rodriguez, E. R. ;
Colvin, R. ;
Conway, J. ;
Hachem, R. ;
Halloran, P. F. ;
Keshavjee, S. ;
Nickerson, P. ;
Murphey, C. ;
O'Leary, J. ;
Reeve, J. ;
Tinckam, K. ;
Reed, E. F. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (03) :562-568
[6]  
Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009
[7]   The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss [J].
Schinstock, C. A. ;
Cosio, F. ;
Cheungpasitporn, W. ;
Dadhania, D. M. ;
Everly, M. J. ;
Samaniego-Picota, M. D. ;
Cornell, L. ;
Stegall, M. D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (06) :1574-1584
[8]   Banff '05 Meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') [J].
Solez, K. ;
Colvin, R. B. ;
Racusen, L. C. ;
Sis, B. ;
Halloran, P. F. ;
Birk, P. E. ;
Campbell, P. M. ;
Cascalho, M. ;
Collins, A. B. ;
Demetris, A. J. ;
Drachenberg, C. B. ;
Gibson, I. W. ;
Grimm, P. C. ;
Haas, M. ;
Lerut, E. ;
Liapis, H. ;
Mannon, R. B. ;
Marcus, P. B. ;
Mengel, M. ;
Mihatsch, M. J. ;
Nankivell, B. J. ;
Nickeleit, V. ;
Papadimitriou, J. C. ;
Platt, J. L. ;
Randhawa, P. ;
Roberts, I. ;
Salinas-Madriga, L. ;
Salomon, D. R. ;
Seron, D. ;
Sheaff, M. ;
Weening, J. J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (03) :518-526
[9]   Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor-Specific Antibody [J].
Wiebe, C. ;
Gibson, I. W. ;
Blydt-Hansen, T. D. ;
Pochinco, D. ;
Birk, P. E. ;
Ho, J. ;
Karpinski, M. ;
Goldberg, A. ;
Storsley, L. ;
Rush, D. N. ;
Nickerson, P. W. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (11) :2921-2930